3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Other solid neoplasm
1
Conditions
Low-grade Glioma
1
Interventions
tovorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Low-grade Glioma
×
tovorafenib
×
Other solid neoplasm
×
Clear all
NCT04775485
2025-04-10
FIREFLY-1
Day One Biopharmaceuticals, Inc.
Phase 2
Recruiting
141 enrolled
1 FDA